These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 20399981

  • 1. Systematic reviews of assessment measures and pharmacologic treatments for agitation.
    Zeller SL, Rhoades RW.
    Clin Ther; 2010 Mar; 32(3):403-25. PubMed ID: 20399981
    [Abstract] [Full Text] [Related]

  • 2. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I, Preval H, Southard R, Francis A.
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [Abstract] [Full Text] [Related]

  • 3. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, Gharabawi GM.
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [Abstract] [Full Text] [Related]

  • 4. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ.
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [Abstract] [Full Text] [Related]

  • 5. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B, Vanelli M, Hyde J, Perez R, Ahokpossi C, Sribney W, Adkison L.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [Abstract] [Full Text] [Related]

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Sep; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 7. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.
    Bieniek SA, Ownby RL, Penalver A, Dominguez RA.
    Pharmacotherapy; 1998 Sep; 18(1):57-62. PubMed ID: 9469682
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
    Martel M, Sterzinger A, Miner J, Clinton J, Biros M.
    Acad Emerg Med; 2005 Dec; 12(12):1167-72. PubMed ID: 16282517
    [Abstract] [Full Text] [Related]

  • 10. Treatments for late-life bipolar disorder.
    Aziz R, Lorberg B, Tampi RR.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
    Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A.
    J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
    [Abstract] [Full Text] [Related]

  • 13. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A.
    Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ, Erdman AR, Booze LL, Scharman EJ, Christianson G, Manoguerra AS, Caravati EM, Chyka PA, Woolf AD, Nelson LS, Troutman WG.
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological management of aggression and violence.
    Humble F, Berk M.
    Hum Psychopharmacol; 2003 Aug; 18(6):423-36. PubMed ID: 12923820
    [Abstract] [Full Text] [Related]

  • 16. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF, Paulsson B, Brecher M.
    J Affect Disord; 2007 Aug; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [Abstract] [Full Text] [Related]

  • 17. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S.
    J Clin Psychiatry; 2003 Aug; 64 Suppl 19():13-8. PubMed ID: 14728085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence-Based Review of Pharmacotherapy for Acute Agitation. Part 1: Onset of Efficacy.
    Zun LS.
    J Emerg Med; 2018 Mar; 54(3):364-374. PubMed ID: 29361326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.